10x Genomics, Inc. (TXG) › Capital Expenditures10x Genomics, Inc. (TXG) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2017: $3.76M2018: $6.28M2019: $42.74M2020: $36.67M2021: $101.28M2022: $131.66M2023: $48.60M2024: $12.39M2025: $5.93M$5.93M2017Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$5.93M-52.1%2024$12.39M-74.5%2023$48.60M-63.1%2022$131.66M+30.0%2021$101.28M+176.2%2020$36.67M-14.2%2019$42.74M+580.2%2018$6.28M+67.3%2017$3.76M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share